Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sports Medicine
Published in: Sports Medicine 4/2015

Open Access 01-04-2015 | Review Article

Mental Health and Physical Activity in Women with Polycystic Ovary Syndrome: A Brief Review

Authors: Francesca Conte, Lauren Banting, Helena J. Teede, Nigel K. Stepto

Published in: Sports Medicine | Issue 4/2015

Login to get access

Abstract

This review was designed to consider the available literature concerning mental health and physical activity in women with polycystic ovary syndrome (PCOS). A systematic approach was taken and two electronic databases (PubMed and EBSCO Research articles published between 1970 and 2013) were searched in 2013 to inform a narrative review. Inclusion criteria encompassed requirements for the research to involve a physical activity intervention and assessment of mental health outcomes in women with PCOS. Seven articles considered mental health outcomes and physical activity interventions for women with PCOS. The results demonstrated positive outcomes following physical activity intervention for health-related quality of life, depression, and anxiety. Only one paper reported the independent effects of physical activity on mental health. All other interventions included multi-factor lifestyle interventions or did not establish a control group. Physical activity is likely to be beneficial to the mental health of women with PCOS; however, more research is required to establish the nature of the relationship between physical activity and mental health outcomes.
Literature
1.
Asuncion M, Calvo R, SanMillan J, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.PubMed
2.
Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.CrossRefPubMed
3.
4.
Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28:2562–9.CrossRefPubMed
5.
March WA, Moore VM, Wilson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–51.CrossRefPubMed
6.
Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–73.CrossRefPubMed
7.
Boyle JA, Cunningham J, O’Dea K, et al. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin. Australia Med J Aust. 2012;196:62–6.CrossRef
8.
Goodarzi MO, Quiñones MJ, Azziz R, et al. Polycystic ovary syndrome in Mexican–Americans: prevalence and association with the severity of insulin resistance. Fertil Steril. 2005;84:766–9.CrossRefPubMed
9.
Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21:1526–32.CrossRefPubMed
10.
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
11.
Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med. 2008;26:39–44.CrossRefPubMed
12.
Cussons AJ, Watts GF, Burke V, et al. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod. 2008;23:2352–8.CrossRefPubMed
13.
Moran LJ, Ranasinha S, Zoungas S, et al. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod. 2013;28:2276–83.CrossRefPubMed
14.
Moran LJ, Strauss BJ, Teede HJ. Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. Fertil Steril. 2011;95:1742–8.CrossRefPubMed
15.
Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum Reprod. 2013;28:777–84.CrossRefPubMed
16.
Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22:2279–86.CrossRefPubMed
17.
Hahn S, Janssen OE, Tan S, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol. 2005;153:853–60.CrossRefPubMed
18.
Li Y, Li Y, Yu Ng EH, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril. 2011;96:452–8.CrossRefPubMed
19.
Deeks AA, Gibson-Helm ME, Paul E, et al. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011 [Epub 2011/03/26].
20.
Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011;26:3339–45.CrossRefPubMed
21.
Bazarganipour F, Ziaei S, Montazeri A, et al. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes. 2013;11:141.CrossRefPubMedCentralPubMed
22.
Benson S, Hahn S, Tan S, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod. 2009;24:1446–51.CrossRefPubMed
23.
Laggari V, Diareme S, Christogiorgos S, et al. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer–Rokitansky–Küster–Hauser syndrome. J Psychosom Obstet Gynaecol. 2009;30:83–8.CrossRefPubMed
24.
Barry J, Kuczmierczyk A, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26:2442–51.CrossRefPubMed
25.
Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22(2):80–6.CrossRefPubMed
26.
Cronin L, Guyatt G, Griffith L, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83:1976–87.PubMed
27.
Eggers S, Kirchegast S. The Polycystic Ovary Syndrome—a medical condition but also an important psychosocial problem. Coll Antropol. 2001;25:673–85.PubMed
28.
29.
Ramezanzadeh F, Aghssa MM, Abedinia N, et al. A survey of relationship between anxiety, depression and duration of infertility. BMC Womens Health. 2004;4(1):9.CrossRefPubMedCentralPubMed
30.
31.
Davis SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab. 2001;12(1):33–7.CrossRefPubMed
32.
Silveira H, Moraes H, Oliveira N, et al. Physical exercise and clinically depressed patients: a systematic review and meta-analysis. Neuropsychobiology. 2013;67(2):61–8.CrossRefPubMed
33.
Pucci GC, Rech CR, Fermino RC, et al. Association between physical activity and quality of life in adults. Rev Saude Publica. 2012;46:166–79.CrossRefPubMed
34.
Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;30:e70.CrossRef
35.
Thomson RL, Buckley JD, Brinkworth GD. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature. Obes Rev. 2011;12(5):e202–10.CrossRefPubMed
36.
Hutchison SK, Stepto NK, Harrison CL, et al. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(1):E48–56. doi:10.​1210/​jc.​2010-0828.CrossRefPubMed
37.
Thomson RL, Buckley JD, Lim SS, et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril. 2010;94(5):1812–6.CrossRefPubMed
38.
Stener-Victorin E, Holm G, Janson PO, et al. Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial. BMC Complement Altern Med. 2013;13:131.CrossRefPubMedCentralPubMed
39.
Nidhi R, Padmalatha V, Nagarathna R, et al. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: a randomized control trial. Int J Yoga. 2012;5:112–7.CrossRefPubMedCentralPubMed
40.
Galletly C, Moran L, Noakes M, et al. Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome—a pilot study. Appetite. 2007;49:590–3.CrossRefPubMed
41.
Ladson G, Dodson WC, Sweet SD, et al. Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Fertil Steril. 2011;95:2595–8.CrossRefPubMedCentralPubMed
42.
Ladson G, Dodson WC, Sweet SD, et al. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril. 2011;95:1059–66.e1–7.
43.
Harris-Glocker M, Davidson K, Kochman L, et al. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. Fertil Steril. 2010;93(3):1016–9.CrossRefPubMedCentralPubMed
44.
Lamb JD, Johnstone EB, Rousseau J-A, et al. Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations. Am J Obstet Gynecol. 2011;204(4):352.e1–6.
45.
46.
47.
48.
49.
50.
Lass N, Kleber M, Winkel K, et al. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab. 2011;96:3533–40.CrossRefPubMed
51.
Teede HJ, Misso ML, Deeks AA, et al. Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195:S65–112.CrossRefPubMed
52.
Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038–49.CrossRefPubMed
53.
Harrison CL, Stepto NK, Hutchison SK, et al. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol. 2012;76:351–7.CrossRef
54.
Curi DD, Fonseca AM, Marcondes JA, et al. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28:182–5.CrossRefPubMed
55.
Thomson RL, Brinkworth GD, Noakes M, et al. The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome. Hum Reprod. 2012;27:2169–76.CrossRefPubMed
56.
Liao LM, Nesic J, Chadwick PM, et al. Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation. Gynecol Endocrinol. 2008;24(10):555–61.CrossRefPubMed
57.
Palomba S, Giallauria F, Falbo A, et al. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod. 2008;23:642–50.CrossRefPubMed
58.
Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470–4.PubMed
59.
Ware JEJ, Sherbourne CD. The MOS 36-Item Short-Form. Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.CrossRefPubMed
60.
61.
62.
Metadata
Title
Mental Health and Physical Activity in Women with Polycystic Ovary Syndrome: A Brief Review
Authors
Francesca Conte
Lauren Banting
Helena J. Teede
Nigel K. Stepto
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 4/2015
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-014-0291-6

Other articles of this Issue 4/2015

Sports Medicine 4/2015 Go to the issue

Letter to the Editor

Correct Wilderness Medicine Definitions and Their Impact on Care

Letter to the Editor

Author’s Reply to Lipman: ‘Correct Wilderness Medicine Definitions and their Impact on Care’

Current Opinion

The Potential Yield of Non-Exercise Physical Activity Energy Expenditure in Public Health

Systematic Review

Effect of Repetition Duration During Resistance Training on Muscle Hypertrophy: A Systematic Review and Meta-Analysis

Review Article

The Science of Badminton: Game Characteristics, Anthropometry, Physiology, Visual Fitness and Biomechanics

Systematic Review

Dose-Response Relationships of Balance Training in Healthy Young Adults: A Systematic Review and Meta-Analysis